Dysregulated apoptosis in primary varicose veins

European Journal of Vascular and Endovascular Surgery

Volumn 29, Issue 3, 2005, Pages 316-323

  Ducasse, Eric ^a,b   Giannakakis, K ^b   Chevalier, J ^c   Dasnoy, D ^c   Puppinck, P ^c   Speziale, F ^a   Fiorani, P ^a   Faraggiana, T ^b  

^a Unit of Vascular Surgery   (France)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Catholic Institute of Lille   (France)

Author keywords

Apoptosis; Mitochondrial pathway; Primary varicose veins; Varicose vein; Vascular apoptosis

Indexed keywords

CASPASE 9; COLLAGEN FIBER; EOSIN; HEMATOXYLIN; MONOCLONAL ANTIBODY; PEROXIDASE; PROTEIN BAX;

ADULT; AGED; APOPTOSIS; ARTERY BYPASS; ARTICLE; BYPASS SURGERY; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ELASTIC FIBER; FEMALE; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RANK SUM TEST; SAPHENOUS VEIN; TISSUE SECTION; TUNICA MEDIA; VARICOSIS; VEIN SURGERY;

ADULT; AGED; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 9; CASPASES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; VARICOSE VEINS;

EID: 13944262586     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejvs.2004.12.012     Document Type: Article

References (50)

1. C.J. Evans F.G. Fowkes C.V. Ruckley A.J. Lee Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study J Epidemiol Commun Health 53 1999 149-153
2. N.S. Sadick Predisposing factors of varicose and telengiectasic leg veins J Dermatol Surg Oncol 18 1992 883-886
3. A. Cornu-Thernard P. Boivin J.M. Baud I. DeVincenzi P.H. Carpentier Importance of the familial factor in varicose disease. Clinical study of 134 families J Dermatol Surg Oncol 20 1994 318-326
4. J.H. Abramson C. Hopp L.M. Epstein The epidemiology of varicose veins. A survey in western Jerusalem J Epidemiol Commun Health 35 1981 213-217
5. A.H. Scultetus J.L. Villavicencio N.M. Rich Facts and fiction surrounding the discovery of the venous valves J Vasc Surg 33 2001 435-441
6. H.D. Moore Deep venous valves in the etiology of varicose veins Lancet 2 1951 7-10
7. N. Labropoulos A.K. Tassiopoulos S.S. Kang M.A. Mansour F.N. Littooy W.H. Baker Prevalence of deep vein incompetence J Vasc Surg 32 2000 663-668
8. L. Andreotti D. Cammelli Connective tissue in varicose veins Angiology 30 1979 798-805
9. L. Andreotti D. Cammelli S. Sampognaro A. Allori D. Baldoni A. Bussotti et al. Biochemical analysis of dermal connective tissue in subjects affected by primary uncomplicated varicose veins Angiology 36 1985 265-270
10. R.H. Gandhi E. Irizarry G.B. Nackman V.J. Halpern R.J. Mulcare M.D. Tilson Analysis of the connective tissue matrix and proteolytic activity of primary varicose veins J Vasc Surg 18 1993 814-820
11. C. Badier-Commander T. Verbeuren C. Lebard J.B. Michel M.P. Jacob Increased TIMP/MMP ratio in varicose veins: Possible explanation for extracellular matrix accumulation J Pathol 192 2000 105-112
12. D.G. Cooper C.S. Hillman-Cooper G.E. Stephen G.E. Barker S.J. Hollingsworth Primary varicose veins: The sapheno-femoral junction, distribution of varicosities and patterns of incompetence Eur J Vasc Endovasc Surg 25 2003 53-59
13. E. Asher J. Theresa A. Hingorani Y. Gunduz F. Mazzariol S. Kallakuri Programmed cell death (Apoptosis) and its role in the pathogenesis of lower extremity varicose veins Ann Chir Vasc 14 2000 24-30
14. E. Ascher T. Jacob A. Hingorani B. Tsemekhin Y. Gundunz Expression of molecular mediators of apoptosis and their role in the pathogenesis of lower-extremity varicose veins J Vasc Surg 33 2001 1080-1086
15. J. Bujan J.A. Jimenez-Cossio F. Jurado M.J. Gimeno G. Pascual B. Garcia-Honduvilla et al. Evaluation of the smooth muscle cell component and apoptosis in the vein wall Histol Histopathol 15 2000 745-752
16. A. Haunstetter S. Izuma Apoptosis: Basic mechanism and implication for cardiovascular disease Circ Res 82 1998 1111-1129
17. A.H. Wyllie Apoptosis: Death gets a brake Nature 369 1994 272-273
18. C.J. Sherr Cancer cell cycles Science 274 1996 1672-1677
19. E.S. Alnemri D.J. Livingston D.W. Nicholson G. Salvesen N.A. Thornberry W.W. Wong et al. Human ICE/CED-3 protease nomenclature Cell 87 1996 171
20. D. Wallach E.E. Varfolomeev N.L. Malinin Y.V. Goltsev A.V. Kovalenko M.P. Boldin Tumor necrosis factor receptor and Fas signaling mechanisms Annu Rev Immunol 17 1999 331-367
21. J. Yuan Transducing signals of life and death Curr Opin Cell Biol 9 1997 247-251
22. J.C. Reed Cytochrome c: Can't live with it; can't live without it Cell 91 1997 559-562
23. D.R. Green J.C. Reed Mitochondria and apoptosis Science 281 1998 1309-1312
24. S.J. Korsmeyer J.R. Shutter D.J. Veis D.E. Merry Z.N. Oltvai Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death Semin Cancer Biol 4 1993 327-332
25. Z.N. Oltvai C.L. Milliman S.J. Korsmeyer Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death Cell 74 1993 609-619
26. J.L. Diaz T. Oltersdorf W. Horne M. McConnel G. Wilson S. Weeks et al. A common binding site mediates heterodimerization and homodimerization of Bcl-2 family members J Biol Chem 272 1997 11350-11355
27. P. Villa S.H. Kaufmann W.C. Earnshaw Caspases and caspase inhibitors Trends Biochem Sci 22 1997 388-393
28. G.M. Cohen Caspases: The executioners of apoptosis Biochem J 326 1997 1-16
29. H.R. Stennicke G.S. Salvesen Properties of the caspases Biochim Biophys Acta 1387 1998 17-31
30. T.F. Panetta M.L. Marin F.J. Veith J. Goldsmith R.E. Gordon A. Jones et al. Unsuspected preexisting saphenous vein disease: An unrecognised cause of vein bypass failure J Vasc Surg 15 1992 102-110
31. M.L. Marin F.J. Veith T.F. Panetta R.E. Gordon K.R. Wengerter W.D. Suggs et al. Saphenous vein biopsy: A predictor of vein graft failure J Vasc Surg 18 1993 407-414
32. R. Sgonc G. Wick Methods for the detection of apoptosis Int Arch Allergy Immunol 105 1995 237
33. M.M. Kockx M.W. Knaapen H.E. Bortier K.M. Cromheeke T. Boutherin O. Falson et al. Vascular remodeling in varicose veins Angiology 49 1998 871-877
34. M. Gougeon L. Montagnier Apoptosis in AIDS Science 260 1993 1269-1270
35. N. Roy M.S. Mahadevan M. McLean G. Shutler Z. Yaraghi R. Farahani et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy Cell 80 1995 167-178
36. Y. Tsujimoto J. Cossman E. Jaffe C. Croce Involvement of the Bcl-2 gene in human follicular lymphoma Science 228 1985 1440-1443
37. L.M. Weiss R.A. Warnke J. Sklar M.L. Cleary Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas N Engl J Med 317 1987 1185-1189
38. G.H. Fisher F.J. Rosenberg S.E. Strauss J.K. Dale L.A. Middelton A.Y. Lin et al. Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome Cell 81 1995 935-946
39. G. Ambrosini C. Adida D. Altieri A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma Nat Med 3 1997 917-921
40. J.C. Reed T. Miyashita S. Takayama H.G. Wang T. Sato S. Krajewski et al. Bcl-2 family proteins: Regulators of cell death involved in the pathogenesis of cancer and resistance to therapy J Cell Biochem 60 1996 23-32
41. E. Durand Z. Mallat F. Addad F. Vilde M. Desnos C. Guerots et al. Time courses of apoptosis and cell proliferation and their relationship to arterial remodeling and restenosis after angioplasty in an atherosclerotic rabbit model J Am Coll Cardiol 39 2002 1680-1685
42. U. Mayr M. Mayr C. Li F. Wernig H. Dietrich Y. Hu et al. Loss of p53 accelerates neointimal lesions of vein bypass grafts in mice Circ Res 90 2002 197-204
43. A. Saxena J.D. McMeekin D.J. Thomson Expression of Bcl-x, Bcl-2, Bax and Bak in endarterectomy and atherectomy specimens J Pathol 196 2002 335-342
44. Z. Jurokova C. Milenkov Ultrastructural evidence for collagen degradation in the walls of varicose veins Exp Mol Pathol 37 1982 37-47
45. P.J. Pappas G.A. Gwertzman D.O. DeFouw F.T. Padberg Jr M.B. Silva Jr W.N. Duran et al. Retinoblastoma protein: A molecular regulator of chronic venous insufficiency J Surg Res 76 1998 149-153
46. H. Zou W.J. Henzel X. Liu A. Lutschg X. Wang Apaf-1, a human protein homologous to C. Elegans CED-4, participates in cytochrome c-dependent activation of caspase 3 Cell 90 1997 405-413
47. H. Zou Y. Li X. Liu X. Wang An Apaf-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase 9 J Biol Chem 274 1999 11549-11556
48. A. Saleh S. Srinivasula S. Acharya R. Fishel E. Alnemri Cytochrome c and dATP-mediated oligomerization of Apaf-1is a prerequisite for procaspase-9 activation J Biol Chem 274 1999 17941-17945
49. K. Kuida T.F. Haydar C.Y. Kuan Y. Gu C. Taya H. Karasuyama et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase-9 Cell 94 1998 325-337
50. R. Hakem A. Hakem G.S. Duncan J.T. Henderson M. Woo M.S. Soengas et al. Differential requirement for caspase-9 in apoptotic pathways in vivo Cell 94 1998 339-352